Clinical Trial

Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to answer the fundamental question, should the physicians choose Surgery or Chemotherapy (SOC-2) in advanced ovarian cancer?
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2016-08-03; most recent amendment 2025-02-06.
Status change: Recruiting → Active, Not Recruiting 2025-02-06
Trial Details
NCT Number NCT02859038
Lead Sponsor Shanghai Gynecologic Oncology Group
Conditions Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
Enrollment 489 participants
Start Date 2016-08
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-02-10